https://www.selleckchem.com/products/sn-38.html
Despite the availability of effective asthma treatments, some patients are poorly controlled due to over-reliance on short-acting β2-agonists (SABAs) and underuse of inhaled corticosteroids (ICS). To identify patient characteristics and outcomes associated with SABA over-reliance and ICS underuse, we conducted a targeted literature review of the quantitative evidence on asthma medication use. Articles evaluating SABA and/or ICS use in asthma patients (aged ≥12 years), published between January 2012 and March 2018 were identified using MED
Gefällt mir
Kommentar
Teilen
